- AU$418.14m
- AU$361.77m
- AU$347.98m
- 76
- 80
- 68
- 85
Annual income statement for Lycopodium, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 208 | 159 | 229 | 326 | 348 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 195 | 141 | 192 | 265 | 281 |
Operating Profit | 13.2 | 17.6 | 37.1 | 60.4 | 67.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.5 | 21.5 | 38.9 | 63.3 | 69.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.7 | 14.1 | 26.9 | 45.6 | 50.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.8 | 14.2 | 27.2 | 46.8 | 50.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.8 | 14.2 | 27.2 | 46.8 | 50.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.296 | 0.355 | 0.684 | 1.18 | 1.28 |
Dividends per Share |